| Use of systemic T-lymphocyte signal transduction inhibitors in the treatment of atopic keratoconjunctivitis. | |
| | |
MedLine Citation:
|
PMID: 18724148 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
PURPOSE: Topical immunomodulators such as tacrolimus have revolutionized the treatment of atopic dermatitis. Because T lymphocytes are integral to the pathogenesis of atopic dermatitis, systemic treatment with T-lymphocyte signal transduction inhibitors should ameliorate both the dermatologic and ocular manifestations. We describe the successful treatment of 6 patients with severe atopic keratoconjunctivitis (AKC) resistant to conventional therapies. METHODS: Retrospective observational case series. The charts of patients with AKC assessed by 1 of the authors were reviewed to identify those treated with systemic T-cell signal transduction inhibitors. Visual acuities, previous treatments, and the response to systemic signal transduction inhibitors were observed and reported in 6 patients. RESULTS: The patients had a mean duration of AKC of 21 years. Topical corticosteroids and antihistamines had failed to control signs and symptoms of the disease in all patients, and in some patients, systemic corticosteroids and topical cyclosporine were ineffective. Three patients were treated with systemic cyclosporine, and 3 were treated with systemic tacrolimus. One patient was subsequently treated with daclizumab in addition to tacrolimus. All 6 patients experienced complete remission of their AKC and an increase in visual acuity. CONCLUSIONS: Selective systemic immunosuppression of T lymphocytes with cyclosporine or tacrolimus has proved effective in the treatment of both atopic dermatitis and atopic keratoconjunctivitis. We advocate the consideration of systemic therapy in cases that are resistant to conventional treatment to resolve inflammation and preserve vision. Further studies in this area are advocated. |
| | |
Authors:
|
Fahd Anzaar; Micheal Joseph Gallagher; Pooja Bhat; Mansoor Arif; Saadia Farooqui; C Stephen Foster |
Related Documents
:
|
15954518 - Sweet syndrome associated with furosemide. 7549838 - Htlv-i positive progressive spastic paraparesis (tsp) associated with a lymphoid disord... 9217188 - Photopheresis in paediatric patients with drug-resistant chronic graft-versus-host dise... 12492968 - Cutaneous findings associated with chronic natural killer cell lymphocytosis. 22036168 - Translational gastrointestinal pharmacology in the 21st century: 'the lesogaberan story' 3429218 - Myasthenia gravis treatment: twelve years experience on 110 patients. |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Cornea Volume: 27 ISSN: 1536-4798 ISO Abbreviation: Cornea Publication Date: 2008 Sep |
Date Detail:
|
Created Date: 2008-08-25 Completed Date: 2008-09-02 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8216186 Medline TA: Cornea Country: United States |
Other Details:
|
Languages: eng Pagination: 884-8 Citation Subset: IM |
Affiliation:
|
Massachusetts Eye Research and Surgery Institute, Cambridge, MA 02142, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Antibodies, Monoclonal / therapeutic use Conjunctivitis, Allergic / drug therapy* Cyclosporine / therapeutic use Drug Therapy, Combination Female Humans Immunoglobulin G / therapeutic use Immunosuppressive Agents / therapeutic use* Infusions, Intravenous Male Middle Aged Retrospective Studies Signal Transduction / drug effects* T-Lymphocytes / drug effects* Tacrolimus / therapeutic use Visual Acuity |
| Chemical | |
Reg. No./Substance:
|
0/Antibodies, Monoclonal; 0/Immunoglobulin G; 0/Immunosuppressive Agents; 109581-93-3/Tacrolimus; 152923-56-3/daclizumab; 59865-13-3/Cyclosporine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Mapping of normal corneal K-structures by in vivo laser confocal microscopy.
Next Document: A comparison of corneal endothelial cell changes after 1-site and 2-site phacotrabeculectomy.